placeholder image
E. L. Mayer All authors
About
Publications While At HealthPartners
Highlights
selected publications
Journal Article
  • Impact of race, socioeconomic status, and clinicopathologic features on clinical outcomes in triple-negative breast cancer in the ECOG-ACRIN EA1131 Trial. 
    JCO Oncol Adv. 2026
  • Adjuvant platinum versus capecitabine for residual, invasive, triple-negative breast cancer: Patient-reported outcomes in ECOG-ACRIN EA1131. 
    Cancer. 2024
  • Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study. 
    Lancet Oncology. 2021
  • Randomized phase III postoperative trial of platinum-based chemotherapy versus capecitabine in patients with residual triple-negative breast cancer following neoadjuvant chemotherapy: ECOG-ACRIN EA1131. 
    Journal of Clinical Oncology. 2021
    • Review
  • Effective strategies for the prevention and mitigation of phosphatidylinositol-3-kinase inhibitor-associated hyperglycemia: optimizing patient care [review]. 
    Clinical Breast Cancer. 2025
    • Contact
    full name
  • E. L. Mayer
    • Quick Info
    Publications
    Publications in the past 10 years based solely on publications while at HealthPartners. Publications in prior years appear in grey.
    Collaboration